Cervical Cancer
Cervical cancer arises from the cervix and involves abnormal cell growth that can invade or spread to other parts of the body. Early stages typically show no symptoms, but later signs may include abnormal vaginal bleeding, pelvic pain, or pain during sexual intercourse.
Health Outcomes
- Activated p53/BAX-Mediated DNA Damage Response
- Cancer Treatment Support
- Enhanced Anticancer Capacity
- Enhanced Antitumor Immunity
- Enhanced Cytolytic Response of CD8+ T Cells
- Genome Sequencing / Genome Characterization
- Improved Adaptive Humoral Response
- Improved Cervical HPV Clearance
- Improved Cervical Lesion Resolution
- Improved Effectiveness in Cancer Treatment
- Improved Health in HIV-Positive Subjects
- Improved Natural Killer Cell Activity
- Improved Natural Killer Cell Tumoricidal Activity
- Improved Vaginal Survival Rate
- Increased Antiangiogenic Activity
- Increased Mitogenic Activity
- Increased NK Cell Activity
- Increased Polyamine Production
- Increased Survival Rate
- Increased Tissue Invasion
- Maintained Natural Killer Cell Activity
- Maintained Vaginal/Cervical Tissue Integrity
- No Serious Treatment-Related Adverse Events
- Overall Treatment Success
- Protection of Cervical Epithelial Barrier
- Reduced Cancer Progression
- Reduced Cancer-Specific Mortality
- Reduced Carcinogenesis
- Reduced Caspase-3 Activity
- Reduced Cervical Inflammation
- Reduced Cervical Intraepithelial Neoplasia
- Reduced Chemotherapy Side Effects
- Reduced Detection of Cervical Intraepithelial Neoplasia
- Reduced HPV Positivity
- Reduced HPV-Related Cervical Lesions
- Reduced Radiation-Associated Diarrhea
- Reduced Risk of Cancer
- Reduced Tumor Downstaging
- Reduced Tumor Stage
- Reduced Tumor Volume